169 related articles for article (PubMed ID: 34084014)
1. A Retrospective Study Supporting the Importance of Individualizing the Dose of Botulinum Toxin According to the Age.
Bravo BSF; Carvalho RM; Gallo BF; Bravo LG
J Cutan Aesthet Surg; 2021; 14(1):88-92. PubMed ID: 34084014
[TBL] [Abstract][Full Text] [Related]
2. An observational study on glabellar wrinkle patterns in Indians.
Kamat A; Quadros T
Indian J Dermatol Venereol Leprol; 2019; 85(2):182-189. PubMed ID: 29620040
[TBL] [Abstract][Full Text] [Related]
3. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.
Blitzer A; Binder WJ; Aviv JE; Keen MS; Brin MF
Arch Otolaryngol Head Neck Surg; 1997 Apr; 123(4):389-92. PubMed ID: 9109785
[TBL] [Abstract][Full Text] [Related]
4. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
[TBL] [Abstract][Full Text] [Related]
5. Safety Profile of Combined Same-Day Treatment for Botulinum Toxin With Full Face Nonablative Fractionated Laser Resurfacing.
Pomerantz H; Akintilo L; Shaw K; Lederhandler M; Anolik R; Geronemus RG
Dermatol Surg; 2021 Apr; 47(4):500-503. PubMed ID: 33165055
[TBL] [Abstract][Full Text] [Related]
6. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics.
Carruthers J; Fagien S; Matarasso SL;
Plast Reconstr Surg; 2004 Nov; 114(6 Suppl):1S-22S. PubMed ID: 15507786
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
8. A study on glabellar wrinkle patterns in Koreans.
Kim HS; Kim C; Cho H; Hwang JY; Kim YS
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1332-9. PubMed ID: 24168325
[TBL] [Abstract][Full Text] [Related]
9. Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis.
Spencer JM; Gordon M; Goldberg DJ
J Cosmet Laser Ther; 2002 Mar; 4(1):19-23. PubMed ID: 12079633
[TBL] [Abstract][Full Text] [Related]
10. Cosmetic Microdroplet Botulinum Toxin A Forehead Lift: A New Treatment Paradigm.
Steinsapir KD; Rootman D; Wulc A; Hwang C
Ophthalmic Plast Reconstr Surg; 2015; 31(4):263-8. PubMed ID: 25216199
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans.
Ahn KY; Park MY; Park DH; Han DG
Plast Reconstr Surg; 2000 Feb; 105(2):778-84. PubMed ID: 10697192
[TBL] [Abstract][Full Text] [Related]
12. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids.
Carruthers A; Carruthers J
Dermatol Surg; 2005 Oct; 31(10):1297-303. PubMed ID: 16188182
[TBL] [Abstract][Full Text] [Related]
13. Global Aesthetics Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.
Sundaram H; Signorini M; Liew S; Trindade de Almeida AR; Wu Y; Vieira Braz A; Fagien S; Goodman GJ; Monheit G; Raspaldo H;
Plast Reconstr Surg; 2016 Mar; 137(3):518e-529e. PubMed ID: 26910696
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids.
Beer KR
Dermatol Surg; 2006 Feb; 32(2):184-97. PubMed ID: 16442037
[TBL] [Abstract][Full Text] [Related]
15. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin: examining duration of effect in facial aesthetic applications.
Flynn TC
Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
[TBL] [Abstract][Full Text] [Related]
17. Full-face treatment with onabotulinumtoxinA: Results from a single-center study.
D'Emilio R; Rosati G
J Cosmet Dermatol; 2020 Apr; 19(4):809-816. PubMed ID: 31486568
[TBL] [Abstract][Full Text] [Related]
18. Muscle Insertion and Strength of the Muscle Contraction as Guidelines to Enhance Duration of the Botulinum Toxin Effect in the Upper Face.
Abramo AC
Aesthetic Plast Surg; 2018 Oct; 42(5):1379-1387. PubMed ID: 29987485
[TBL] [Abstract][Full Text] [Related]
19. The clinical effect of botulinum toxin on pigmentation.
Erdil D; Manav V; Türk CB; Kara Polat A; Koku Aksu AE
Int J Dermatol; 2023 Feb; 62(2):250-256. PubMed ID: 36468824
[TBL] [Abstract][Full Text] [Related]
20. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
Beer KR; Julius H; Dunn M; Wilson F
J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
